Summary
Cetuximab plus chemotherapy and radiation therapy does not improve clinical complete response rates or overall survival (OS) in patients with locally advanced esophageal cancer. This article presents data from the Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer trial [RTOG 0436; Ilson D et al. Ann Oncol 2014 (abstr O-0005)].
- Head & Neck Cancers
- Gastrointestinal Cancers Clinical Trials
- Head & Neck Cancers
- Gastrointestinal Cancers Clinical Trials
- © 2014 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.